Avantor stock holds focus after raised 2026 outlook

Published on 11/10/2026 at 22:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Avantor stock returned to organic growth in the third quarter. Management lifted its 2026 revenue, adjusted EPS and free cash flow outlook.

Growth and guidance improve

Third-quarter sales increased 4.6% year over year, while organic growth reached 5.2%.
Avantor raised its 2026 organic revenue, adjusted EPS and free cash flow guidance after the quarterly update.

AVTR, US05352A1007, Illustration mit AI erstellt.

Avantor reported a return to year-over-year growth for the quarter ended September 30, 2026, and raised several full-year targets. The company announced the update on October 28 in its investor release.

Organic growth returns

Net sales rose 4.6% year over year to 1,698.3 million US dollars in the third quarter. After excluding foreign-exchange effects, organic sales increased 5.2%. VWR Distribution & Services delivered 5.8% organic growth, while Bioscience & Medtech Products grew 3.6% organically.

GAAP net income was 203.4 million US dollars, compared with a net loss of 711.8 million US dollars in the prior-year quarter, which included a 785.0 million US dollar non-cash goodwill impairment charge. Adjusted EPS was 0.22 US dollars, and adjusted EBITDA reached 256.9 million US dollars with a 15.1% margin.

Targets move higher

Avantor raised its 2026 organic revenue growth outlook to 0.75% to 1.25% from negative 0.5% to positive 0.5%. The adjusted EPS range moved to 0.81 to 0.83 US dollars from 0.80 to 0.83 US dollars, while free cash flow guidance increased to 525 million to 550 million US dollars, excluding cash restructuring costs. The adjusted EBITDA margin range remained 14.8% to 15.3%.

Avantor stock traded at 13.96 euros on Lang & Schwarz at 22:41 CET on Tuesday, November 10, 2026.